
Medicinal Chemistry Research p. 74 - 105 (2005)
Update date:2022-08-03
Topics:
Goud, P. Mallikarjun
Sheri, Anjaneyulu
Desai, Prashant V.
Watkins, E. Blake
Tekwani, Babu
Sabnis, Yogesh
Gut, Jiri
Rosenthal, Philip J.
Avery, Mitchell A.
The Plasmodium falciparum cysteine proteases, falcipains, have been established as novel targets for antimalarial drug design. Using the de novo design approach, several trisubstituted thiazole analogs were generated as potential inhibitors of these enzymes. A general and convenient synthetic approach for these novel trisubstituted thiazoles is reported here. Substituents at the 4th and 5th positions of the target thiazoles were introduced by a Hantzsch reaction, and the chain at the second position was extended through a Sandmeyer reaction, formylation, and Wittig olefination. In vitro enzyme inhibition studies have identified three inhibitors (14, 16, 23) of the falcipains with one (14) showing dual activity against both falcipain-2 and falcipain-3 and IC50 values of 6.6 and 29.4 μM, respectively. Birkhaeuser Boston 2005.
View MoreTaizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Contact:+86-710-3516804
Address:Number 83,Panggong road,Xiangcheng District,Xiangyang ,Hubei
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Doi:10.3390/molecules24152780
(2019)Doi:10.1016/S0040-4039(01)99802-8
(1983)Doi:10.1248/cpb.41.1074
(1993)Doi:10.1007/BF00515363
(1983)Doi:10.1039/d0ob00998a
(2020)Doi:10.1016/S0040-4039(00)94163-7
(1983)